作者: Amina Zoubeidi , Karen Ferrante , Vincent C. O. Njar , Douglas B. Jacoby , Eva Corey
DOI:
关键词: Androgen receptor 、 Prostate cancer 、 Oncology 、 Androgen 、 Castration resistant 、 Internal medicine 、 Medicine
摘要: Described herein are methods and compositions for the treatment of prostate cancer in a subject need thereof. The may be castration resistant an androgen receptor antagonist-resistant cancer. comprise administering to CYP17-lyase inhibitor Formula II.